Effects of Community-Embedded Care Management Model on Patients, Providers, and Payers

November 2018 Vol 9, NO 11
Sheryl Riley, RN, OCN, CMCN
Director of Clinical Services,
SAI Systems,
Shelton, CT

Background: Comprehensive oncology care management builds on expert clinical support and coordinated services but lacks a community focus during critical phases of the cancer journey. A community-embedded approach can fill this crucial gap by extending oncology programs past practice walls, incorporating local resources, and identifying barriers to care between office visits.

Objectives: The cycle of care management adheres to the following objectives:

  • Improve health outcomes
  • Engage the patient, their family, and healthcare team
  • Advance payer efficiency and cost savings
  • Support the treatment plan in the community

Methods: Saisystems Health deploys a risk-based process implemented through proprietary stratification software, intriCare. The solution compiles all data points of the healthcare system for analysis, including pharma, HRA, claims, disability, and more. Based on these factors, our team calculates a 3-step risk acuity score for each patient to assure treatment plans meet their individual needs. Patients are then designated to care programs in accordance with their risk levels. This allows for personalized care plans and staff workflows that produce optimal health outcomes. Care teams of a care coordinator, registered nurse, and social worker provide consistent healthcare navigation, monitor patients’ treatment adherence, and work to improve health outcomes. They act as a safety net for patients and their families at all times. The continuous flow of communication allows team members to cohesively evaluate various aspects of care and communicate with patients’ other primary health providers.


  • 9.6% decrease in emergency department visits
  • 24.7% decrease in hospital admissions
  • 22% improvement in medication adherence
  • 20% increase in member compliance
  • 8.4% cost savings from smarter spending
  • 12.5% rate of scheduled MD visits versus unscheduled
  • Hospice conversion at 8 times the national average
  • Improved side effects management
  • Return on investment of 3:1

Conclusion: Through community-embedded oncology care management, patients not only receive the proper level of care but also show various improved health outcomes. Providers and patients experience decreased emergency department visits, shorter hospital stays, and improved quality of life, whereas payers realize tremendous cost savings due to smarter spending and utilization management strategies. Practices continue to recognize community-embedded care management as a transformative standard of treatment that is central to positive health outcomes. However, as the health community pushes to implement this type of treatment in more practices, we recognize an ethical duty to learn as much as possible and improve on our methods. As part of quality assurance initiatives, Saisystems Health conducts constant evaluations of quality metrics to ensure our teams are providing the very best to patients, providers, and payers.

Related Articles
Assessment of Side Effects (SEs) Impacting Quality of Life (QOL) in Patients (Pts) Undergoing Treatment (tx) for Advanced Breast Cancer (ABC) in Clinical Practice: A Real-World (RW) Multicountry Survey
November 2022 Vol 13, No 11
To examine how SEs impacting QOL in pts with ABC are perceived.
Intracranial Activity of Tepotinib in Patients with MET Exon 14 (METex14) Skipping Non–Small-Cell Lung Cancer (NSCLC) Enrolled in VISION
November 2022 Vol 13, No 11
To provide analysis of the intracranial activity of tepotinib in patients with METex14 skipping NSCLC with BM from the VISION study to aid oncology nurse navigators who manage this population of patients.
MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor
November 2022 Vol 13, No 11
MF is a rare bone marrow cancer characterized by fibrosis, abnormal blood cell production, and dysregulated JAK/STAT signaling.1,2
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
    Profession or Role
    Primary Specialty or Disease State